4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole, 97%, 250mg

2-Amino-1-(2-chlorophenyl)ethanol hydrochloride, 95.0%, 100mg

Dodecanamide, N-[(3S)-tetrahydro-2-oxo-3-furanyl]-, 98%, 50mg

9,9-Dimethyl-2,7-bis[N-(m-tolyl)anilino]fluorene>98.0%(HPLC)(N)1g

3-[(3R)-Piperidin-3-yl]-1,3-oxazinan-2-one hydrochloride, 1g

1,2-Bis(4-hydroxyphenyl)ethane-1,2-dione, 95.0%, 5g

3-Bromo-2,4-dimethyl-1,8-naphthyridine, 95.0%, 500mg

2-m-Tolyl-ethanesulfonyl chloride, 50mg

Reaktionsgefäß, zyl., gradu., Flachboden, DN60, 0,5 l, 1 Stück

4-(3-methylphenyl)butanoic acid, 95.0%, 250mg

6-Bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-amine, 98%, 100mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valine>98.0%(HPLC)(T)5g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-6-dihydropyridine-1(2H)-carboxylate, 98.0%, 100g